|
CNN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.92120000000107E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.71430000001283E-06 |
| Normal-vs-Stage2 |
8.555200E-01 |
| Normal-vs-Stage3 |
1.496110E-03 |
| Normal-vs-Stage4 |
3.516900E-03 |
| Stage1-vs-Stage2 |
2.045000E-03 |
| Stage1-vs-Stage3 |
5.103600E-01 |
| Stage1-vs-Stage4 |
5.924200E-01 |
| Stage2-vs-Stage3 |
2.290000E-02 |
| Stage2-vs-Stage4 |
2.981600E-02 |
| Stage3-vs-Stage4 |
9.863400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.007800000008E-06 |
| Normal-vs-AfricanAmerican |
2.966400E-02 |
| Normal-vs-Asian |
3.959200E-03 |
| Caucasian-vs-AfricanAmerican |
9.791000E-01 |
| Caucasian-vs-Asian |
7.482800E-01 |
| AfricanAmerican-vs-Asian |
8.598000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.480600E-03 |
| Normal-vs-Female |
1.85202999999357E-05 |
| Male-vs-Female |
2.251000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.76420000000499E-07 |
| Normal-vs-Age(41-60Yrs) |
2.964700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.251400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.923800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.905600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.365000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.469000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.448150E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.658200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.875000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.779400E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
5.476600E-01 |
| Classical-VS-Normal |
3.40490002859184E-09 |
| Tall-VS-Follicular |
1.53710377759353E-11 |
| Tall-VS-Other |
5.478400E-01 |
| Tall-VS-Normal |
2.19069999995991E-06 |
| Follicular-VS-Other |
9.309700E-02 |
| Follicular-VS-Normal |
4.121400E-03 |
| Other-VS-Normal |
3.198600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.239990E-01 |
| Normal-vs-N1 |
2.823800E-03 |
| N0-vs-N1 |
2.887600E-02 |
|
|
